Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium

被引:53
作者
Yao, Q [1 ]
Wang, S [1 ]
Gambotto, A [1 ]
Glorioso, JC [1 ]
Evans, CH [1 ]
Robbins, PD [1 ]
Ghivizzani, SC [1 ]
Oligino, TJ [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
关键词
arthritis; TRAIL; apoptosis; gene therapy; adenovirus;
D O I
10.1038/sj.gt.3301881
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that primarily affects joints. In rheumatoid joints there is extensive synovial proliferation with diseased synovium becoming highly aggressive, attaching to the articular cartilage and bone to form what is termed a pannus. The formation of active pannus is central to erosive disease and resulting joint destruction. In this study, we examined the ability to eliminate the hyperplastic synovium by adenoviralmediated gene transfer of human TNF-related apoptosisinducing ligand (TRAIL), a member of the TNF family that is able to induce apoptosis through interaction with receptors containing death domains, DR4 and DR5. Infection of synovial cells derived from RA patients with Ad.TRAIL resulted in significant apoptosis in three out of five lines. Moreover, primary rabbit synovial fibroblasts were also sensitive to Ad.TRAIL-mediated gene transfer. In a rabbit model of arthritis, intra-articular gene transfer of TRAIL induced apoptosis in cells within the synovial lining, reduced leukocytic infiltration and stimulated new matrix synthesis by cartilage. These results demonstrate that TRAIL can affect the viability of the cells populating the activated synovium in arthritic joints and suggest that the delivery of TRAIL to arthritic joints may represent a non-invasive mechanism for inducing pannus regression. Gene Therapy (2003) 10,1055-1060. doi:10.1038/sj.gt.3301881.
引用
收藏
页码:1055 / 1060
页数:6
相关论文
共 29 条
  • [1] CONSTITUTIVE PRODUCTION OF INFLAMMATORY AND MITOGENIC CYTOKINES BY RHEUMATOID SYNOVIAL FIBROBLASTS
    BUCALA, R
    RITCHLIN, C
    WINCHESTER, R
    CERAMI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) : 569 - 574
  • [2] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [3] Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
    Emery, JG
    McDonnell, P
    Burke, MB
    Deen, KC
    Lyn, S
    Silverman, C
    Dul, E
    Appelbaum, ER
    Eichman, C
    DiPrinzio, R
    Dodds, RA
    James, IE
    Rosenberg, M
    Lee, JC
    Young, PR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) : 14363 - 14367
  • [4] APOPTOSIS IN RHEUMATOID-ARTHRITIS SYNOVIUM
    FIRESTEIN, GS
    YEO, M
    ZVAIFLER, NJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) : 1631 - 1638
  • [5] Invasive fibroblast-like synoviocytes in rheumatoid arthritis - Passive responders or transformed aggressors?
    Firestein, GS
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (11): : 1781 - 1790
  • [6] DIFFERENTIAL EXPRESSION OF THE SMALL INDUCIBLE CYTOKINES GRO-ALPHA AND GRO-BETA BY SYNOVIAL FIBROBLASTS IN CHRONIC ARTHRITIS - POSSIBLE ROLE IN GROWTH-REGULATION
    HOGAN, M
    SHERRY, B
    RITCHLIN, C
    FABRE, M
    WINCHESTER, R
    CERAMI, A
    BUCALA, R
    [J]. CYTOKINE, 1994, 6 (01) : 61 - 69
  • [7] TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy
    Lincz, LF
    Yeh, TX
    Spencer, A
    [J]. LEUKEMIA, 2001, 15 (10) : 1650 - 1657
  • [8] A novel receptor for Apo2L/TRAIL contains a truncated death domain
    Marsters, SA
    Sheridan, JP
    Pitti, RM
    Huang, A
    Skubatch, M
    Baldwin, D
    Yuan, J
    Gurney, A
    Goddard, AD
    Godowski, P
    Ashkenazi, A
    [J]. CURRENT BIOLOGY, 1997, 7 (12) : 1003 - 1006
  • [9] Activation of synoviocytes
    Müller-Ladner, U
    Gay, RE
    Gay, S
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (03) : 186 - 194
  • [10] MullerLadner U, 1996, AM J PATHOL, V149, P1607